ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
184 hedge funds and large institutions have $2.41B invested in Array Biopharma Inc in 2017 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 182 → 184 (+2)
5% more call options, than puts
Call options by funds: $32.6M | Put options by funds: $31.1M
Holders
184
Holding in Top 10
4
Calls
$32.6M
Puts
$31.1M
Top Buyers
| 1 | +$81.2M | |
| 2 | +$45.6M | |
| 3 | +$44.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.6M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$28.6M |
Top Sellers
| 1 | -$44.7M | |
| 2 | -$25.7M | |
| 3 | -$9.35M | |
| 4 |
Renaissance Technologies
New York
|
-$8.29M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.86M |